Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
